Replies to post #9693 on Amarin Corp Plc (AMRN)

[wmjenkins3938]

Off label promotion has only recently been prosecuted as it is today, they got away with it previously

[jtf3]

What KC has addressed is important- we don't really know the number of patients that comprised the Anchor population. I'm concerned that only minority of that population will be prescribed Vascepa. What that # is, who knows? Of course, if the outcome trial came up positive, it's an entirely different story,